Page 444 - ILAE_Lectures_2015

62. MEADOR KJ, BAKER GA, BROWNING N (2013) Fetal antiepileptic drug exposure and cognitive outcomes
at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 12, 244-252.

63. ROTH C, MAGNUS P, SCHJOLBERG S et al (2011) Folic acid supplements in pregnancy and severe
language delay in children. JAMA 306(14), 1566-1573.

64. CHATZI L, PAPADOPOULOU E, KOUTRA K et al (2012) Effect of high doses of folic acid
supplementation in early pregnancy on child neurodevelopment at 18 months of age: the mother-child cohort
‘Rhea’ study in Crete, Greece. Public Health Nutr 15(9), 1728-1736.

65. SABERS A: Complications during pregnancy and delivery. In: Epilepsy and Pregnancy. Tomson T, Gram L,
Sillanpaa M, Johannessen SI (Eds) Wrightson Biomedical Publishing Ltd, Petersfield, UK (1997): 105-111.

66. YERBY M, KOEPSELL T, DALING J (1985) Pregnancy complications and outcomes in a cohort of women
with epilepsy. Epilepsy 26, 631-635.

67. HIILESMAA VK, BARDY A, TERAMO K (1985) Obstetric outcome in women with epilepsy. Am J Obstet
Gynecol 152, 499-504.

68. NELSON KB, ELLENBERG JH (1982) Maternal seizure disorder, outcome of pregnancy, and neurologic
abnormalities in the children. Neurology 32, 1247-1254.

69. YERBY MS, CAWTHORN L (1994) Mortality rates in infants of mothers with epilepsy. Ann Neurol 36, 330.
70. MARTIN PJ, MILLAC PAH (1993) Pregnancy, epilepsy, management and outcome: a 10 year perspective.

Seizure 2, 277-280.
71. BECH BH, KJAERSGAARD MIS, PEDERSEN HS et al (2014) Use of antiepileptic drugs during pregnancy

and risk of spontaneous abortion and stillbirth: population based cohort study. BMJ 349, g5159.
72. LAOSOMBAT V (1988) Hemorrhagic disease of the newborn after maternal anticonvulsant therapy: a case

report and literature review. J Med Assoc Thai 71, 643-648.
73. CORNELISSEN M, STEEGERS-THEUNISSEN R, KOLLEE L et al (1993) Increased incidence of neonatal

vitamin K deficiency resulting from maternal anticonvulsant therapy. Am J Obstet Gynecol 168, 923-928.
74. HOWE AM, OAKES DJ, WOODMAN PDC, WEBSTER WS (1999) Prothrombin and PIVKA-II levels in

cord blood from newborns exposed to anticonvulsants during pregnancy. Epilepsia 40, 980-984.
75. CORNELISSEN M, STEEGERS-THEUNISSEN R, KOLLEE L, ESKES T, MOTOHARA K, MONNENS

L (1993) Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents
neonatal vitamin K deficiency. Am J Obstet Gynecol 168, 884-888.
76. QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY
(1998) Practice parameter: Management issues for women with epilepsy (summary statement). Neurology 51,
944-948.
77. CRAWFORD P, APPLETON R, BETTS T et al (1999) Best practice guidelines for the management of
women with epilepsy. Seizure 8, 201-217.
78. KAAJA E KAAJA R, MATILA R, HIILESMAA V. Enzyme-inducing antiepileptic drugs in pregnancy and
the risk of bleeding in the neonate. Neurology 58, 549-553.
79. HARDEN CL, PENNELL PB, KOPPEL S et al (2009) Practice parameter update: management issues for
women with epilepsy- Focus on pregnancy (an evidence based review): Vitamin K, folic acid, blood levels
and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology
Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
Neurology 73, 142-149.
80. THE EURAP STUDY GROUP (2006) Seizure control and treatment in pregnancy. Observations from the
EURAP Epilepsy Pregnancy Registry. Neurology 66, 354-360.
81. WILLIAMS J, MYSON V, STERARD S et al (2002) Self-discontinuation of antiepileptic medication in
pregnancy: detection by hair analysis. Epilepsia 43, 824-831.
82. PERUCCA E, CREMA A (1982) Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet 7, 336-
352.
83. LANDER CM, EADIE MJ (1991) Plasma antiepileptic drug concentrations during pregnancy. Epilepsia 32,
257-266.
84. YERBY MS, FRIEL PN, MCCORMACK K: Antiepileptic drug disposition during pregnancy. Neurology
(1992) 42 (Suppl 5):12-16.
85. TOMSON T, OHMAN I, VITOLS S. (1997) Lamotrigine in pregnancy and lactation: a case report. Epilepsia
38, 1039-41.
86. OHMAN I, VITOLS S, TOMSON (2000) Lamotrigine in pregnancy: pharmacokinetics during delivery, in
the neonate, and during lactation. Epilepsia 41, 709-713.
87. TRAN TA, LEPPIK IE, BLESI K et al (2002) Lamotrigine clearance during pregnancy. Neurology 59, 251-
255.
88. PENNELL PB, NEWPORT DJ, STOWE ZN et al (2004) The impact of pregnancy and childbirth on the
metabolism of lamotrigine. Neurology 62, 292-295.
89. DEHAAN GJ, EDELBROEK P, SEGERS J et al (2004) Gestation-induced changes in lamotrigine
pharmacokinetics: a monotherapy study. Neurology 63, 571-573.
90. PENNELL PB, PENG L, NEWPORT DJ, et al (2008) Lamotrigine in pregnancy. Clearance, therapeutic drug
monitoring and seizure frequency. Neurology 70, 2130-2136.
91. SABERS A, PETRENAITE V (2009) Seizure frequency in pregnant women treated with lamotrigine
monotherapy. Epilepsia 50, 2163-2166.
92. TERAMO K, HIILESMAA V, BARDY A, SAARIKOSKI S (1979) Fetal heart rate during a maternal
grandmal epileptic seizure. J Perinat Med 7, 3-6.
93. DEVINSKY O, YERBY MS (1994) Women with epilepsy: reproduction and effects of pregnancy on epilepsy.
Neurologic Clinics 12, 479-495.